New research suggests that introducing peanuts early in infancy is linked with fewer peanut and overall food allergy diagnoses, and eggs now top the list of childhood food allergens. A 2025 multi-practice analysis tied the earlier feeding guidance to measurable declines, built on the foundation of the LEAP trial and later policy updates encouraging early exposure. The study shows promise but also has limits: it used electronic health records, stopped data collection before 2021 guidance changes, and cannot prove causation. Parents are advised to talk with their pediatrician before trying any new feeding approach for infants.
For decades parents were told to hold off on feeding peanuts to babies, but that advice shifted after clinical trials showed early exposure could prevent allergies. The landmark LEAP trial found that infants at high risk who were given peanut between 4 and 11 months had dramatically lower rates of peanut allergy. That trial reframed the thinking in pediatrics, moving the conversation from avoidance to early, controlled introduction in many cases. The newer guidelines and follow-up studies have tested whether that change actually moved the needle across broader populations.
The 2025 study led by clinicians at the Children’s Hospital of Philadelphia reviewed pediatric medical records from practices across the country and reported a 27% drop in peanut allergy diagnoses. It also observed a 38% decline in overall food allergy diagnoses during the interval examined, suggesting the early-introduction strategy may have broader benefits. Interestingly, eggs have now overtaken peanuts as the most common food allergen in the children included in this analysis. Other frequent culprits remain milk and wheat, highlighting that peanut-focused policy is only one part of the allergy picture.
Federal and specialty guidance changed after LEAP, with the National Institute of Allergy and Infectious Diseases and other bodies endorsing earlier introduction for at-risk infants. Guidance was updated again in 2021 to encourage introducing peanut, egg and other major allergens as early as 4 to 6 months for all children, not just those at high risk. The new Pediatrics paper concentrated on the two years after the earlier guidance and captured signals that the recommendations may be having an effect. That timeline matters because feeding practices and dissemination take time to reach families and clinicians nationwide.
“Everyone has been wondering whether these landmark public health interventions have had an impact on reducing rates of IgE-mediated food allergies in the United States,” said first author Stanislaw Gabryszewski, M.D., Ph.D., an attending physician in the Division of Allergy and Immunology at the Children’s Hospital of Philadelphia, in a statement. “We now have data that suggest the effect of this landmark public health intervention is occurring.” Those comments reflect cautious optimism from the researchers rather than definitive proof, but they do suggest the clinical trials and guidelines influenced real-world outcomes.
The study authors added that the latest findings “are supportive of efforts to increase education and advocacy related to early food introduction practices,” and noted, “If confirmed, these findings would represent a meaningful public health advance — affirming that clinical research, when coupled with clear guidelines and committed dissemination, can indeed shift the trajectory of childhood food allergy.” That framing highlights the role of clear messaging and clinician support when translating trial results into everyday pediatric care. It also underscores how public health gains often depend on both evidence and the systems that spread it.
There are important caveats. The analysis used records through early 2019, so it did not reflect the broader 2021 guidance that encouraged early introduction across the board. Reliance on electronic health record diagnoses means some cases may be missed or misclassified, and the researchers did not have data on exactly how or when individual infants were fed. Because the study was observational, it can only show association rather than prove that early introduction caused the decline in diagnoses, and other factors could be involved.
Peanut allergy can trigger severe reactions in some children, including trouble breathing, throat swelling and a dangerous drop in blood pressure, and those episodes require immediate treatment with epinephrine. Not every parent will feel comfortable with early introduction rules, and uptake has not been uniform. “Not everyone has followed those guidelines, but this is further evidence that this early introduction is effective at preventing food allergies,” said Dr. Susan Schuval, chief of the Division of Pediatric Allergy and Immunology at Stony Brook Children’s Hospital. Families should weigh benefits and risks and bring up concerns with their pediatrician before introducing potential allergens.
